The Roche Board of Directors will propose Christoph Franz to be elected as Chairman of the Board.

Humer, who announced at the last shareholder conference that he would not be standing for re-election. Christoph Franz will not renew his agreement as CEO of the Lufthansa Group, which expires on 31 May 2014. Commenting on the nomination of Christoph Franz, Roche Chairman Franz B. Humer stated: With Christoph Franz, Roche gets a chairman with outstanding personal characteristics and an extraordinary record as head of a major global business.Dr. We were impressed by their international reach also, an important requirement given that one of the Phase 3 trials with AMR101 will be conducted across several international regions like the U.S. As many as 28 million people in the U.S. Possess elevated blood triglyceride levels, a significant risk factor for cardiovascular morbidity and mortality. AMR101, an ultra-pure, prescription quality ethyl-EPA product, supplies the potential to become a novel, secure and efficient therapy for this condition.S.